AG Paxton secures a deal with Purdue Pharma for bankruptcy reorganization, creating Knoa Pharma and a Master Creditor Trust.

STAMFORD, Conn.--(BUSINESS WIRE)--The United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”) today indicated it will approve the Chapter 11 Plan of ...

Purdue Pharma’s bankruptcy plan was approved by a federal judge Sept. 1, meaning the company that made and marketed the opioid Oxycontin will be dissolved, The New York Times reported. Judge Robert ...

Court clears path Purdue Pharma opioid settlement, confirming the $7.5B plan and enabling victim compensation and company reorganization.

NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...

Purdue Pharma said Friday that the U.S. Bankruptcy Court for the Southern District of New York has indicated it intends to approve the company’s long-running Chapter 11 reorganization plan, a step ...

(NEW YORK) -- Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler ...

The Supreme Court blocked an earlier version of Purdue’s bankruptcy settlement. Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no ...